日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ROS-Responsive Hydrogel for Localized Delivery of Nampt and Stat3 Inhibitors Exhibits Synergistic Antitumor Effects in Colorectal Cancer Through Ferroptosis Induction and Immune Microenvironment Remodeling.

ROS响应型水凝胶可局部递送Nampt和Stat3抑制剂,通过诱导铁死亡和重塑免疫微环境,在结直肠癌中表现出协同抗肿瘤作用

Ye Chenyang, Mi Mi, Shi Saimeng, Qi Lina, Weng Shanshan, Wang Lu, Lu Yier, Chen Chao, Tan Yinuo, Yang Mengyuan, Guo Cheng, Bai Rui, Fang Xuefeng, Wang Ji, Yuan Ying

The Development of p53-Targeted Therapies for Human Cancers

针对人类癌症的p53靶向疗法的发展

Lu, Yier; Wu, Meng; Xu, Yang; Yu, Lili

Global burden of tracheal, bronchus, and lung cancer attributable to occupational carcinogens in 204 countries and territories, from 1990 to 2019: results from the global burden of disease study 2019

1990年至2019年204个国家和地区职业致癌物导致的气管癌、支气管癌和肺癌的全球负担:2019年全球疾病负担研究结果

Zhang, Yan; Mi, Mi; Zhu, Ning; Yuan, Zhijun; Ding, Yuwei; Zhao, Yingxin; Lu, Yier; Weng, Shanshan; Yuan, Ying

Ferroptosis regulator FANCD2 is associated with immune infiltration and predicts worse prognosis in lung adenocarcinoma

铁死亡调节因子FANCD2与免疫浸润相关,并预示肺腺癌预后不良。

Ye, Chenyang; Lu, Yier; Yuan, Zhijun; Mi, Mi; Qi, Lina; Yuan, Ying; Weng, Shanshan

REV1: A novel biomarker and potential therapeutic target for various cancers

REV1:一种新型生物标志物和多种癌症的潜在治疗靶点

Zhu, Ning; Zhao, Yingxin; Mi, Mi; Lu, Yier; Tan, Yinuo; Fang, Xuefeng; Weng, Shanshan; Yuan, Ying